PGNX - Progenics Pharmaceuticals Stock Price - Barchart.com Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced financial results for the fourth quarter and full-year 2019. PGNX: 3.11 It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. PGNX Stock Price Quote & News - Progenics Pharmaceuticals ... View the real-time PGNX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Progenics Pharmaceuticals against related stocks people have also bought like GERN, VKTX, VSTM, and TEVA. 2,069 people own Progenics Pharmaceuticals on Robinhood on April 4, 2020. Progenics Pharmaceuticals Stock Forecast: up to 3.798 USD ...
Stock analysis for Progenics Pharmaceuticals Inc (PGNX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
In depth view into PGNX (Progenics Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. View detailed financial information, real-time news, videos, quotes and analysis on Progenics Pharmaceuticals Inc. (NASDAQ:PGNX). Explore commentary on Progenics Pharmaceuticals Inc. and hear what the experts at TheStreet are saying Progenics Pharmaceuticals, Inc Stock Chart and Share Price Forecast, Short- Term "PGNX" Stock Prediction Short Volume: Total number of short shares traded on the major US markets each day; Short Volume Ratio: Total number of short shares traded divided by the total shares traded each day (lower chart). PGNX / Progenics Pharmaceuticals, Inc. View Progenics Pharmaceuticals, Inc.'s fair value, stock price, financial statements, news, valuation models, fundamental charts, margin of safety, and more. Here is What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX). Is Progenics Pharmaceuticals (NASDAQ:PGNX) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Last updated Saturday March 28th 12: 08pm. 9 Aug 2018 HL is BULLISH on Progenics Pharmaceuticals Inc., with a target price of 9.13 Progenics Pharmaceuticals $PGNX stock was down 6% today despite announcing successful phase 2b data of Azedra in malignant/recurrent
Real time Progenics Pharmaceuticals (PGNX) stock price quote, stock graph, news & analysis.
PGNX | Progenics Pharmaceuticals Inc. Stock Price & News - WSJ View the latest Progenics Pharmaceuticals Inc. (PGNX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock ... Progenics Pharmaceuticals Inc. Common Stock (PGNX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Progenics Pharmaceuticals - PGNX - Stock Price & News ...
Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
In total, 1.04 million shares bought and sold for approximately $3.36 million. PGNX Stock Price Summary. 30 day high of the PGNX stock price was $4.23 and low was $1.89. 90 day high was $5.37
Jul 19, 2016 · PGNX has traded 166,781 shares today. PGNX is trading at 4.34 times the normal volume for the stock at this time of day. Looking at the price performance of PGNX's shares over the past 12 Progenics Pharmaceuticals Inc. - NASDAQ:PGNX - Stock Quote ...